Add to ORKGEarlier this year, the Department of Health and Human Services (HHS) proposed changes to the current pricing and contracting system for federal health care programs, Medicare Part D and Medicaid.This proposal aligns with the Trump Administration’s blueprint for lowering drug prices which we have written about previously
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
After Medicare's implementation of the bundled payment for dialysis in 2011, there has been a predic...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...
The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for inc...
Prohibiting gag clauses could help lower consumer out-of-pocket pharmacy costs - if Pharmacy Benefit...
Congress may reform drug pricing policies under Medicare Part D as part of a larger health reform ef...
Mckenzie Taylor continues our monthly conversation on the strategies presented in The Trump Administ...
The Medicaid Drug Rebate Program helps lower Medicaid spending on outpatient prescription drugs by e...
Importance: The US Department of Health and Human Services (HHS) has proposed to reform drug pricing...
The cost of brand-name drugs in the United States is up to four times higher than in other countries...
Background Insurers manage the cost of specialty medicines via rebates, however it is unclear if the...
When Congress was debating the Medicare drug benefit in 2003, there were many who advocated that Med...
The United States healthcare system is one of the most expensive in the world. Unlike other products...
Since the early 2000s, state Medicaid programs have made concerted efforts to control the cost of pr...
The 340B drug pricing program was created to improve access to outpatient medications for low-income...
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
After Medicare's implementation of the bundled payment for dialysis in 2011, there has been a predic...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...
The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs calls for inc...
Prohibiting gag clauses could help lower consumer out-of-pocket pharmacy costs - if Pharmacy Benefit...
Congress may reform drug pricing policies under Medicare Part D as part of a larger health reform ef...
Mckenzie Taylor continues our monthly conversation on the strategies presented in The Trump Administ...
The Medicaid Drug Rebate Program helps lower Medicaid spending on outpatient prescription drugs by e...
Importance: The US Department of Health and Human Services (HHS) has proposed to reform drug pricing...
The cost of brand-name drugs in the United States is up to four times higher than in other countries...
Background Insurers manage the cost of specialty medicines via rebates, however it is unclear if the...
When Congress was debating the Medicare drug benefit in 2003, there were many who advocated that Med...
The United States healthcare system is one of the most expensive in the world. Unlike other products...
Since the early 2000s, state Medicaid programs have made concerted efforts to control the cost of pr...
The 340B drug pricing program was created to improve access to outpatient medications for low-income...
The U.S. Congress passed a new law (PL 101-508) in 1990 requiring the pharmaceutical manufacturers t...
After Medicare's implementation of the bundled payment for dialysis in 2011, there has been a predic...
Medicare Part D began coverage of prescription drugs in 2006. Rather than setting pharmaceutical pri...